您的位置: 首页 > 农业专利 > 详情页

Modulation of Factor 7 expression
专利权人:
Inc.;Isis Pharmaceuticals
发明人:
Monia, Brett P.,Crosby, Jeffrey R.,Zhao, Chenguang,Freier, Susan M.,Zhang, Hong
申请号:
AU2008323970
公开号:
AU2008323970B2
申请日:
2008.11.05
申请国别(地区):
AU
年份:
2014
代理人:
摘要:
Disclosed herein are antisense compounds and methods for decreasing Factor7 and treating or preventing thromboembolic complications, hyperproliferativedisorders, or inflammatory conditions in an individual in need thereof. Examplesof disease conditions that can be ameliorated with the administration of antisensecompounds targeted to Factor 7 include thrombosis, embolism, and thromboembolism,such as, deep vein thrombosis, pulmonary embolism, myocardial infarction,stroke, cancer, rheumatoid arthritis, and fibrosis.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充